Pharma Business - May 12, 2026
Bavarian Nordic awarded contract options from US Government
The Center for the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 97 million under the existing contract to supply a freeze-dried formulation of JYNNEOS smallpox vaccine.
Event Highlights - May 8, 2026
Highlights from Vitalis
As the largest Nordic event for digital health, health tech, person-centered care, Vitalis 2026 did indeed bring together the full life science and healthcare ecosystems.
Biotech Business - May 6, 2026
NextCell and FUJIFILM Biosciences launch commercial platform
The two companies have announced a global commercial launch resulting from their strategic collaboration.
Event Highlights - May 5, 2026
Highlights from Vitalis
As the largest Nordic event for digital health, health tech, person-centered care, Vitalis 2026 did indeed bring together the full life science and healthcare ecosystems.
Financing - May 4, 2026
Moleculent raises USD 20 million
The financing round was led by Rubicon Healthcare Partners, with participation from ARCH Venture Partners, Eir Ventures, and other existing investors.
In a new job - May 4, 2026
He is the new CEO of NADMED
James Lee brings more than 25 years of experience in the international pharmaceutical and healthcare sector, with a track record of launching innovative medicines and scaling global healthcare brands, according to the company.
